We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NMR:NYSENomura Holdings Inc analysis

Data as of Sep 11, 2026 - not real-time

Latest price
$10.87
Risk: medium
6/10Medium risk

Summary

Nomura Holdings, Inc. trades at $10.87, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has gained 13.7% over the past 30 days. RSI sits at 71.4, which reads as overbought, and MACD momentum is bullish. Recent trading has carved out support near $9.45 and resistance around $10.94.
On valuation the read is fair — earnings multiple of 12.5 versus a 16.2 sector average, below the peer group. The average analyst target implies 5.1% below today's level. Revenue is growing at 31.2% on a 17.3% profit margin. The 3.10% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 22.8%, a beta of 1.24 and a maximum drawdown of 22.4%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 4 out of 10.

Top market events

  • Nomura Holdings Inc NMR reports significant growth in wealth management and global markets, despite challenges in...
  • Nomura crushed Q1 expectations with $0.30 EPS, blowing past the $0.23 estimate as wholesale trading gains and...
  • Detailed price information for Nomura Holdings Inc ADR NMR-N from The Globe and Mail including charting and trades.

Market outlook

Short term

< 1 year

Positive

Model confidence6/106 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 71.4 signals overbought conditions
  • Trading above the 200-day average of 8.76

Medium term

1–3 years

Positive

Model confidence5/105 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 71.4 signals overbought conditions
  • P/E of 12.5 versus sector average of 16.2

Long term

> 3 years

Positive

Model confidence4/104 out of 10

Key factors

  • P/E of 12.5 versus sector average of 16.2
  • Analyst targets imply -5.1% versus the current price
  • Profit margin of 17.3% is healthy

Key metrics

Financial health

Revenue Growth31.20%
Profit Margin17.29%
P/E Ratio12.5
ROE11.16%
ROA0.67%
Debt/Equity945.61
P/B Ratio1.3
Industry P/E16.2

Technical analysis

TrendBullish
RSI71.4
Support$9.45
Resistance$10.94
MA 20$10.12
MA 50$9.86
MA 200$8.76
MACDBullish
VolumeIncreasing
Fear & Greed Index93.09

Valuation

Target Price$10.31
Upside/Downside-5.13%
GradeFair
TypeValue
Dividend Yield3.10%

Risk assessment

Beta1.24
Volatility22.84%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.